EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer

Yang Liu, Wei Xu, Mingxue Li, Yueying Yang, Dejuan Sun, Lidian Chen, Hua Li, Lixia Chen

Acta Pharmaceutica Sinica B · 2023-04 · 13 (4) · 1438-1466

DOI: 10.1016/j.apsb.2022.12.019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-04. Verfasst von Yang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, She…. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Liaoning Province, Fujian University of Traditional Chinese Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CancerD-2HGEpigeneticsIDH1IDH1 inhibitorsImmune microenvironmentMetabolic reprogrammingRegulatory mechanisms

Autor:innen und Institutionen

  • Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Institute of Structural Pharmacology & TCM Chemical Biology, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
  • The Institute of Rehabilitation Industry, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.

Förderung

  • Natural Science Foundation of Liaoning Province
  • Fujian University of Traditional Chinese Medicine
  • National Natural Science Foundation of China

Zitieren

APA

Liu, Y., Xu, W., Li, M., Yang, Y., Sun, D., Chen, L., Li, H., & Chen, L. (2023). The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer. Acta Pharmaceutica Sinica B, 13(4), 1438-1466. https://doi.org/10.1016/j.apsb.2022.12.019

Vancouver

Liu Y, Xu W, Li M, Yang Y, Sun D, Chen L, et al. The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer. Acta Pharmaceutica Sinica B. 2023;13(4):1438-1466. doi:10.1016/j.apsb.2022.12.019

BibTeX
@article{Liu2023,
  author = {Liu, Yang and Xu, Wei and Li, Mingxue and Yang, Yueying and Sun, Dejuan and Chen, Lidian and Li, Hua and Chen, Lixia},
  title = {The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2023},
  volume = {13},
  number = {4},
  pages = {1438--1466},
  doi = {10.1016/j.apsb.2022.12.019}
}
Kostenlos starten →